After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will ...
Investors continue to reward Haemonetics with higher market valuations in 2023. Driving these trends are the firm's attractive underlying economic characteristics. This includes high capital returns ...
Astria Therapeutics (ATXS) had made some good progress with respect to its pipeline. That's because it was able to announce positive preliminary results in human patients using STAR-0215 as a ...
Hereditary angioedema (HAE) is a condition that causes swelling, or edema, in different parts of the body. It mainly affects the upper respiratory tract, skin, and abdomen. HAE is a type of angioedema ...
Hereditary angioedema (HAE) is a rare genetic disorder that causes episodes of severe swelling throughout your body. It is caused by abnormal immune responses. But unlike allergic swelling, HAE is not ...
Swelling in hereditary angioedema (HAE) can arise from exposure to triggers like stress, infection, and injury. For some people, dietary triggers can also be a cause of HAE swelling episodes.
Even if you’re doing everything you can to avoid an episode of hereditary angioedema (HAE) — dodging injuries, preventing respiratory illnesses, taking medication — it’s not always possible to ward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results